Avance Clinical, a contract research organisation (CRO) for biotechs, has announced the appointment of Jessica Han as Director, Asian Operations based out of Avance Clinical’s Seoul, Korea office.

The formal announcement will be made at BIO Taiwan, in the Australian Pavilion, at the Taipei International Convention Centre (July 26 – 28).

Jessica’s career began as a registered nurse in the critical care unit at Samsung Medical Center, where she focused on patient care and clinical research. Transitioning into the clinical trial sector, she has worked in various roles at leading contract research organisations in the region, such as Parexel, PRA Health Sciences (now ICON), and Novotech.

Avance Clinical CEO Yvonne Lungershausen said, “With over 17 years of experience in the healthcare and clinical research industry, and a deep understanding of the Asian market, and in particular the Korean market, Jessica Han is set to drive Avance Clinical's operations and strategic initiatives across Asia”.

The expansion into South Korea and Asia aligns with Avance Clinical's GlobalReady drug development solution, which has already garnered significant interest from over 75 Korean biotechs and pharmaceutical companies.